Running Update:
9/11/2018
|
Run
|
|
3.2 mi
|
31:36
|
9/12/2018
|
Run
|
|
7.6 mi
|
1:16:50
|
9/14/2018
|
Run
|
|
5.0 mi
|
47:40
|
9/15/2018
|
Swim
|
|
1600.0 yd
|
|
9/16/2018
|
Run
|
|
10.2 mi
|
1:46:14
|
9/18/2018
|
Run
|
|
3.2 mi
|
30:41
|
9/19/2018
|
Run
|
|
7.6 mi
|
1:15:44
|
9/21/2018
|
Run
|
|
5.0 mi
|
47:58
|
9/23/2018
|
Run
|
|
20.5 mi
|
3:30:47
|
9/26/2018
|
Run
|
|
3.1 mi
|
30:35
|
9/28/2018
|
Run
|
|
5.0 mi
|
48:56
|
Less than a
month until the Marine Corps Marathon! I
have one more 20+ mile run to go next weekend before I start to taper. Yay!
As always, you can donate to our campaign here:
NF Update:
This week we
finally received the final results of Jane’s MRI from our visit to NIH earlier
this month. Unfortunately, her tumor volume showed a
little uptick, as you can see in the plot above. Dr Widemann called it a “very minimal
increase by numbers, which is within error of measurement.” That said, she went on to say, “I think we made the right decision
increasing the selumetinib dose.”
I do, too.
For background: Jane’s dose of selumetinib is based on body surface area, or BSA, a
combination of height and weight measured in square meters. Her height and weight are measured every 6 months
at our NIH visits and her dose is adjusted accordingly. The full dose of selumetinib for Jane would
be 50mg/m2/day. However, ever since Jane
had a skin reaction to selumetinib shortly after she started the medication four
years ago, she has been on 30% less than a full dose (as was required by the
study protocol). That means her target
dose right now is about 35mg/m2/day, which translates to 30mg twice a day, what
Jane has been taking since our visit to NIH 3 weeks ago.
Given that Jane herself is growing so fast, and that it now looks
like her tumor is growing again, too, I was nervous about waiting a whole six
months to recalculate and/or increase her dose again. Thankfully, Dr Widemann agrees: “I think it would be absolutely fine to check the BSA again in 3 months
at home, especially as JC is undergoing so much change right now. We could then
dose adjust depending on BSA.”
So, we’ll continue 30mg twice a
day until the beginning of December and see how much taller Jane is at that
point. I’ll admit, I’m not thrilled to
see the increase in Jane’s tumor, however slight, but will try to remember that
it does not necessarily mean this will continue.